Vincent J. Burgess's most recent trade in TELA Bio Inc was a trade of 11,700 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TELA Bio Inc | Vincent J. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 11,700 | 11,700 | - | - | Stock Option (Right to Buy) | |
| TELA Bio Inc | Vincent J. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 7,950 | 23,330 (0%) | 0% | 0 | Common Stock | |
| TELA Bio Inc | Vincent J. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,200 | 6,200 | - | - | Stock Option (Right to Buy) | |
| TELA Bio Inc | Vincent J. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 4,250 | 15,380 (0%) | 0% | 0 | Common Stock | |
| TELA Bio Inc | Vincent J. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 5,360 | 5,360 | - | - | Stock Option (Right to Buy) | |
| TELA Bio Inc | Vincent J. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 3,135 | 11,130 (0%) | 0% | 0 | Common Stock | |
| TELA Bio Inc | Vincent J. Burgess | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 4,860 | 0 | - | - | Stock Option (Right to Buy) | |
| TELA Bio Inc | Vincent J. Burgess | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.44 per share. | 29 Mar 2023 | 4,860 | 7,995 (0%) | 0% | 4.4 | 21,578 | Common Stock |
| TELA Bio Inc | Vincent J. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 5,360 | 5,360 | - | - | Stock Option (Right to Buy) | |
| TELA Bio Inc | Vincent J. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 3,135 | 3,135 (0%) | 0% | 0 | Common Stock | |
| Acutus Medical Inc | Vincent J. Burgess | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.30 per share. | 01 Apr 2022 | 3,896 | 61,469 | - | 1.3 | 5,065 | Common Stock |
| Acutus Medical Inc | Vincent J. Burgess | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.52 per share. | 05 Aug 2021 | 1,922 | 65,365 | - | 15.5 | 29,829 | Common Stock |
| TELA Bio Inc | Vincent J. Burgess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 10,825 | 10,825 | - | - | Stock Option (Right to Buy) | |
| Acutus Medical Inc | Vincent J. Burgess | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 158,691 | 158,691 | - | - | Stock Options (Right to Buy) | |
| Acutus Medical Inc | Vincent J. Burgess | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 45,065 | 67,287 | - | 0 | Common Stock |